Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Medscape Interviews Dr. Carla LoPinto-Khoury about New Meta-Analysis Examining the Use of Carbamazepine and Its Impact on Vitamin D Levels

View All News

Medscape interviewed Carla LoPinto-Khoury, MD, Associate Professor of Neurology at the Lewis Katz School of Medicine at Temple University, about a new meta-analysis published in the December issue of Epilepsy Research. The meta-analysis examined the use of carbamazepine, which is widely used for epilepsy and psychiatric conditions, and its impact on vitamin D levels. Dr. LoPinto-Khoury, who was part of the meta-analysis, recommends monitoring patients taking carbamazepine and their basic metabolic liver function, blood counts and vitamin D levels to see if supplementation or alternative medications are needed.